92 results on '"Futterer J"'
Search Results
2. Performance of single-use syringe versus multi-use MR contrast injectors: a prospective comparative study
- Author
-
Struik, F., Futterer, J. J., and Prokop, W. M.
- Published
- 2020
- Full Text
- View/download PDF
3. Abstract No. 9 ▪ FEATURED ABSTRACT Pivotal Study of Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation (TULSA) of the Prostate: 4-year Follow-up
- Author
-
Raman, S., primary, Arora, S., additional, Macura, K., additional, Oto, A., additional, Futterer, J., additional, Staruch, R., additional, Tirkes, T., additional, Bonekamp, D., additional, Haider, M., additional, Cool, D., additional, Nandalur, K., additional, Nicolau, C., additional, Costa, D., additional, Persigehl, T., additional, Clarke, G., additional, Chin, J., additional, Klotz, L., additional, and Eggener, S., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project
- Author
-
Scheltema, M. J., Tay, K. J., Postema, A. W., de Bruin, D. M., Feller, J., Futterer, J. J., George, A. K., Gupta, R. T., Kahmann, F., Kastner, C., Laguna, M. P., Natarajan, S., Rais-Bahrami, S., Rastinehad, A. R., de Reijke, T. M., Salomon, G., Stone, N., van Velthoven, R., Villani, R., Villers, A., Walz, J., Polascik, T. J., and de la Rosette, J. J. M. C. H.
- Published
- 2017
- Full Text
- View/download PDF
5. Pitfalls in Interpreting mp-MRI of the Prostate: A Pictorial Review with Pathologic Correlation
- Author
-
Panebianco, V., Barchetti, F., Barentsz, J., Ciardi, A., Cornud, F., Futterer, J., and Villeirs, G.
- Published
- 2015
- Full Text
- View/download PDF
6. Definitions of Computer-Assisted Surgery and Intervention, Image-Guided Surgery and Intervention, Hybrid Operating Room, and Guidance Systems: Strasbourg International Consensus Study: Strasbourg International Consensus Study
- Author
-
Giménez, M. (Mariano) E. (Eduardo), Gallix, B. (Benoit), Costamagna, G. (G), Vauthey, J. (J) N. (N), Moche, M. (M), Wakabayashi, G. (G), Bale, R. (R), Swanström, L. (Lee), Futterer, J. (J), Geller, D. (D), Verde, J. (Juan) M. (M), García Vazquez, A. (Alain), Boškoski, I. (I), Golse, N. (N), Müller-Stich, B. (B), Dallemagne, B. (Bernard), Falkenberg, M. (M), Jonas, S. (S), Riediger, C. (C), Diana, M. (Michele), Kvarnström, N. (N), Odisio, B. (B) C. (C), Serra, E. (E), Overduin, C. (C), Palermo, M. (M), Mutter, D. (Didier), Perretta, S. (Silvana), Pessaux, P. (Patrick), Soler, L. (L), Hostettler, A. (Alexandre), Collins, T. (Toby), Cotin, S. (Stéphane), Kostrzewa, M. (Michael), Alzaga, A. (A), Smith, M. (M), and Marescaux, J. (Jacques)
- Subjects
Aucun ,Sciences du Vivant [q-bio]/Médecine humaine et pathologie - Abstract
OBJECTIVE: To develop consensus definitions of image-guided surgery, computer-assisted surgery, hybrid operating room, and surgical navigation systems. SUMMARY BACKGROUND DATA: The use of minimally invasive procedures has increased tremendously over the past 2 decades, but terminology related to image-guided minimally invasive procedures has not been standardized, which is a barrier to clear communication. METHODS: Experts in image-guided techniques and specialized engineers were invited to engage in a systematic process to develop consensus definitions of the key terms listed above. The process was designed following review of common consensus-development methodologies and included participation in 4 online surveys and a post-surveys face-to-face panel meeting held in Strasbourg, France. RESULTS: The experts settled on the terms computer-assisted surgery and intervention, image-guided surgery and intervention, hybrid operating room, and guidance systems and agreed-upon definitions of these terms, with rates of consensus of more than 80% for each term. The methodology used proved to be a compelling strategy to overcome the current difficulties related to data growth rates and technological convergence in this field. CONCLUSIONS: Our multidisciplinary collaborative approach resulted in consensus definitions that may improve communication, knowledge transfer, collaboration, and research in the rapidly changing field of image-guided minimally invasive techniques. PMC7771637
- Published
- 2020
7. Tissue-specific silencing of a transgene in rice
- Author
-
Kloti, A., He, X., Potrykus, I., Hohn, T., and Futterer, J.
- Subjects
Methylation -- Physiological aspects ,DNA binding proteins -- Physiological aspects ,Rice -- Genetic aspects ,Science and technology - Abstract
In a transgenic rice line, [beta]-glucuronidase reporter gene under the control of the rice tungro bacilliform virus promoter became gradually methylated, and gene activity was lost concomitantly. Methylation was observed only in the homozygous offspring and was initially restricted to the promoter region and accompanied by loss of expression in the vascular bundle tissue only. This expression pattern was similar to that of a promoter with a deletion of a vascular bundle expression element. The gene activity could be reestablished by treatment with 5-azacytidine. Methylation per se did not inhibit the binding to the promoter region of protein factors which also bound to the unmethylated sequence. Instead, promoter methylation enabled the alternative binding of a protein with specificity for sequence and methylation. In further generations of homozygous offspring the methylation spread into the transcribed region and gene activity was completely repressed also in nonvascular cells. The results indicate that different stages are involved in DNA methylation-correlated gene inactivation, and that at least one of them may involve the attraction of a sequence and methylation-specific DNA-binding protein.
- Published
- 2002
8. Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?
- Author
-
Marra G, Ploussard G, Futterer J, Valerio M, De Visschere PJL, Tsaur I, Tilki D, Ost P, Gandaglia G, Van den Bergh RCN, Surcel C, Kretschmer A, Heidegger I, Borgmann H, Mathieu R, Marra, G, Ploussard, G, Futterer, J, Valerio, M, De Visschere, Pjl, Tsaur, I, Tilki, D, Ost, P, Gandaglia, G, Van den Bergh, Rcn, Surcel, C, Kretschmer, A, Heidegger, I, Borgmann, H, and Mathieu, R
- Subjects
Nephrology ,Image-Guided Biopsy ,Male ,medicine.medical_specialty ,Cognitive ,MRI ,Prostate biopsy ,Targeted biopsy ,Transperineal ,Transrectal ,Biopsy ,Humans ,Image Processing, Computer-Assisted ,Magnetic Resonance Imaging, Interventional ,Perineum ,Prostate ,Prostatic Neoplasms ,Rectum ,Software ,Urology ,Image Processing ,030232 urology & nephrology ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Computer-Assisted ,Internal medicine ,medicine ,Medical physics ,medicine.diagnostic_test ,Interventional ,business.industry ,Cancer ,Cognition ,medicine.disease ,Magnetic Resonance Imaging ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Urological cancers Radboud Institute for Health Sciences [Radboudumc 15] ,business - Abstract
Item does not contain fulltext PURPOSE: To review the evidence addressing current controversies around prostate biopsy. Specific questions explored were (1) mpMRI targeted (TgBx) alone versus combined with systematic (SBx) biopsy; (2) cognitive versus software-based targeted biopsy; (3) transrectal or transperineal route (TP). METHODS: We performed a literature search of peer-reviewed English language articles using PubMed and the words "prostate" AND "biopsy". Web search was implemented by manual search. RESULTS: Prostate mpMRI is revolutionizing prostate cancer (PCa) diagnosis, and TgBx improves the detection of clinically significant (cs) PCa compared to SBx alone. The utility of combining SBx-TgBx is variable, but in non-expert centres the two should be combined to overcome learning curve-limitations. Whether SBx should be maintained in expert centres depends on what rate of missed cancer the urological community and patients are prone to accept; this has implications for insignificant cancer diagnosis as well. TgBx may be more precise using a software-based-approach despite cognitive TgBx proved non-inferior in some studies, and may be used for large accessible lesions. TP-biopsies are feasible in an in-office setting. Avoidance of the rectum and accessibility of virtually all prostate areas are attractive features. However, this has to be balanced with local setting and resources implications. Ongoing trials will shed light on unsolved issues. CONCLUSION: The prostate biopsy strategy should be tailored to local expertise, needs and resources availability. Targeted biopsy enhance the ratio between cs and insignificant cancer diagnosis, although some csPCa might be missed. Software-based TgBx are likely to be more precise, especially for new users, although the additional cost might be not justified in all cases. TPBx have ideal attributes for performing TgBx and avoiding infection, although this has resources implications.
- Published
- 2019
9. 3:45 PM Abstract No. 341 Pivotal study of magnetic resonance imaging–guided transurethral ultrasound ablation in men with localized prostate cancer: 12-month clinical and imaging outcomes
- Author
-
Raman, S., primary, Futterer, J., additional, Oto, A., additional, Arora, S., additional, Tirkes, T., additional, Macura, K., additional, Bonekamp, D., additional, Haider, M., additional, Cool, D., additional, Nandalur, K., additional, Nicolau, C., additional, Costa, D., additional, Persigehl, T., additional, Purysko, A., additional, Staruch, R., additional, Burtnyk, M., additional, Chin, J., additional, Klotz, L., additional, and Eggener, S., additional
- Published
- 2020
- Full Text
- View/download PDF
10. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees
- Author
-
Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, Reijke, T M De, Santis, M De, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, Kwast, T Van Der, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, Bari, B De, Blok, W De, De Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Mir, M Carmen, Moschini, M, Mostafid, H, Müller, A-C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, Sherif, Amir, Smeenk, R J, Smits, A, Stenzl, A, Thalmann, G N, Tombal, B, Turkbey, B, Lauridsen, S Vahr, Valdagni, R, Van Der Heijden, A G, Van Poppel, H, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Rivera, F A Vives, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R, Witjes, J A, Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, Reijke, T M De, Santis, M De, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, Kwast, T Van Der, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, Bari, B De, Blok, W De, De Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Mir, M Carmen, Moschini, M, Mostafid, H, Müller, A-C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, Sherif, Amir, Smeenk, R J, Smits, A, Stenzl, A, Thalmann, G N, Tombal, B, Turkbey, B, Lauridsen, S Vahr, Valdagni, R, Van Der Heijden, A G, Van Poppel, H, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Rivera, F A Vives, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R, and Witjes, J A
- Abstract
BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. SETTING: Online Delphi survey and consensus conference. PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. CONCLUSIONS: These consensus sta
- Published
- 2019
- Full Text
- View/download PDF
11. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
- Author
-
UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service d'urologie, Witjes, J A, Van Der Heijden, A G, Smits, A, Stenzl, A, Thalmann, G N, Tombal, Bertrand, Turkbey, B, Lauridsen, S Vahr, Valdagni, R, Van Poppel, H, Sherif, A, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Rivera, F A Vives, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R, Smeenk, R J, Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, Reijke, T M De, Santis, M De, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, Kwast, T Van Der, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, Bari, B De, Blok, W De, De Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Mir, M Carmen, Moschini, M, Mostafid, H, Müller, A-C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service d'urologie, Witjes, J A, Van Der Heijden, A G, Smits, A, Stenzl, A, Thalmann, G N, Tombal, Bertrand, Turkbey, B, Lauridsen, S Vahr, Valdagni, R, Van Poppel, H, Sherif, A, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Rivera, F A Vives, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R, Smeenk, R J, Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, Reijke, T M De, Santis, M De, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, Kwast, T Van Der, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, Bari, B De, Blok, W De, De Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Mir, M Carmen, Moschini, M, Mostafid, H, Müller, A-C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, and Sengupta, S
- Abstract
BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. SETTING: Online Delphi survey and consensus conference. PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. CONCLUSIONS: These consensus sta
- Published
- 2019
12. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†
- Author
-
Cancer, Verpleegkundig Specialisten, MS Urologische Oncologie, Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, Reijke, T M De, Santis, M De, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, Kwast, T Van Der, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, Bari, B De, Blok, W De, De Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Mir, M Carmen, Moschini, M, Mostafid, H, Müller, A-C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, Sherif, A, Smeenk, R J, Smits, A, Stenzl, A, Thalmann, G N, Tombal, B, Turkbey, B, Lauridsen, S Vahr, Valdagni, R, Van Der Heijden, A G, Van Poppel, H, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Rivera, F A Vives, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R, Witjes, J A, Cancer, Verpleegkundig Specialisten, MS Urologische Oncologie, Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, Reijke, T M De, Santis, M De, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, Kwast, T Van Der, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, Bari, B De, Blok, W De, De Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Mir, M Carmen, Moschini, M, Mostafid, H, Müller, A-C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, Sherif, A, Smeenk, R J, Smits, A, Stenzl, A, Thalmann, G N, Tombal, B, Turkbey, B, Lauridsen, S Vahr, Valdagni, R, Van Der Heijden, A G, Van Poppel, H, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Rivera, F A Vives, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R, and Witjes, J A
- Published
- 2019
13. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort:under the auspices of the EAU and ESMO Guidelines Committees†
- Author
-
Horwich, A., Babjuk, M., Bellmunt, J., Bruins, H. M., Reijke, T. M.De, Santis, M. De, Gillessen, S., James, N., Maclennan, S., Palou, J., Powles, T., Ribal, M. J., Shariat, S. F., Kwast, T. Van Der, Xylinas, E., Agarwal, N., Arends, T., Bamias, A., Birtle, A., Black, P. C., Bochner, B. H., Bolla, M., Boormans, J. L., Bossi, A., Briganti, A., Brummelhuis, I., Burger, M., Castellano, D., Cathomas, R., Chiti, A., Choudhury, A., Compérat, E., Crabb, S., Culine, S., Bari, B. De, Blok, W. De, De Visschere, P. J.L., Decaestecker, K., Dimitropoulos, K., Dominguez-Escrig, J. L., Fanti, S., Fonteyne, V., Frydenberg, M., Futterer, J. J., Gakis, G., Geavlete, B., Gontero, P., Grubmüller, B., Hafeez, S., Hansel, D. E., Hartmann, A., Hayne, D., Henry, A. M., Hernandez, V., Herr, H., Herrmann, K., Hoskin, P., Huguet, J., Jereczek-Fossa, B. A., Jones, R., Kamat, A. M., Khoo, V., Kiltie, A. E., Krege, S., Ladoire, S., Lara, P. C., Leliveld, A., Linares-Espinós, E., Løgager, V., Lorch, A., Loriot, Y., Meijer, R., Mir, M. Carmen, Moschini, M., Mostafid, H., Müller, A. C., Müller, C. R., N'Dow, J., Necchi, A., Neuzillet, Y., Oddens, J. R., Oldenburg, J., Osanto, S., Oyen, W. J.G., Pacheco-Figueiredo, L., Pappot, H., Patel, M. I., Pieters, B. R., Plass, K., Remzi, M., Retz, M., Richenberg, J., Rink, M., Roghmann, F., Rosenberg, J. E., Rouprêt, M., Rouvière, O., Salembier, C., Salminen, A., Sargos, P., Sengupta, S., Sherif, A., Smeenk, R. J., Smits, A., Stenzl, A., Thalmann, G. N., Tombal, B., Turkbey, B., Lauridsen, S. Vahr, Valdagni, R., Van Der Heijden, A. G., Van Poppel, H., Vartolomei, M. D., Veskimäe, E., Vilaseca, A., Rivera, F. A.Vives, Wiegel, T., Wiklund, P., Williams, A., Zigeuner, R., Witjes, J. A., Horwich, A., Babjuk, M., Bellmunt, J., Bruins, H. M., Reijke, T. M.De, Santis, M. De, Gillessen, S., James, N., Maclennan, S., Palou, J., Powles, T., Ribal, M. J., Shariat, S. F., Kwast, T. Van Der, Xylinas, E., Agarwal, N., Arends, T., Bamias, A., Birtle, A., Black, P. C., Bochner, B. H., Bolla, M., Boormans, J. L., Bossi, A., Briganti, A., Brummelhuis, I., Burger, M., Castellano, D., Cathomas, R., Chiti, A., Choudhury, A., Compérat, E., Crabb, S., Culine, S., Bari, B. De, Blok, W. De, De Visschere, P. J.L., Decaestecker, K., Dimitropoulos, K., Dominguez-Escrig, J. L., Fanti, S., Fonteyne, V., Frydenberg, M., Futterer, J. J., Gakis, G., Geavlete, B., Gontero, P., Grubmüller, B., Hafeez, S., Hansel, D. E., Hartmann, A., Hayne, D., Henry, A. M., Hernandez, V., Herr, H., Herrmann, K., Hoskin, P., Huguet, J., Jereczek-Fossa, B. A., Jones, R., Kamat, A. M., Khoo, V., Kiltie, A. E., Krege, S., Ladoire, S., Lara, P. C., Leliveld, A., Linares-Espinós, E., Løgager, V., Lorch, A., Loriot, Y., Meijer, R., Mir, M. Carmen, Moschini, M., Mostafid, H., Müller, A. C., Müller, C. R., N'Dow, J., Necchi, A., Neuzillet, Y., Oddens, J. R., Oldenburg, J., Osanto, S., Oyen, W. J.G., Pacheco-Figueiredo, L., Pappot, H., Patel, M. I., Pieters, B. R., Plass, K., Remzi, M., Retz, M., Richenberg, J., Rink, M., Roghmann, F., Rosenberg, J. E., Rouprêt, M., Rouvière, O., Salembier, C., Salminen, A., Sargos, P., Sengupta, S., Sherif, A., Smeenk, R. J., Smits, A., Stenzl, A., Thalmann, G. N., Tombal, B., Turkbey, B., Lauridsen, S. Vahr, Valdagni, R., Van Der Heijden, A. G., Van Poppel, H., Vartolomei, M. D., Veskimäe, E., Vilaseca, A., Rivera, F. A.Vives, Wiegel, T., Wiklund, P., Williams, A., Zigeuner, R., and Witjes, J. A.
- Abstract
BACKGROUND: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference. SETTING: Online Delphi survey and consensus conference. PARTICIPANTS: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus). RESULTS AND LIMITATIONS: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease. CONCLUSIONS: These consensus
- Published
- 2019
14. Medical students' perspective on training in anatomy
- Author
-
Triepels, C. P. R., Koppes, D. M., Van Kuijk, S. M. J., Popeijus, H. E., Lamers, W. H., van Gorp, T., Futterer, J. J., Kruitwagen, R. F. P. M., Notten, K. J. B., Triepels, C. P. R., Koppes, D. M., Van Kuijk, S. M. J., Popeijus, H. E., Lamers, W. H., van Gorp, T., Futterer, J. J., Kruitwagen, R. F. P. M., and Notten, K. J. B.
- Abstract
Gaining sufficient knowledge of anatomy is an important part of medical education. Factors that influence how well students learn anatomical structures include available sources, learning time and study assistance. This study explores the attitude of medical students with regard to studying anatomy and evaluates possibilities for improvement of training in anatomy. Twenty medical students participated in a focus group meeting. Based on this focus group, an online survey consisting of 27 questions was developed and distributed amongst medical students of Maastricht University, the Netherlands. A total of 495 medical students (both Bachelor and Master level) participated in this survey. Master students found studying anatomy less attractive than Bachelor students (36.8% of the Master students vs. 47.9% of the Bachelor students (p = .024)). Although most students responded that they thought it is important to study anatomy, 48% of all students studied anatomy less than 10 h per study block of 8 weeks. Only 47.9% of the students rated their knowledge of anatomy as adequate. Students suggested that three-dimensional techniques would help improve their knowledge of anatomy. Therefore investing in three-dimensional tools could prove beneficial in the future. (C) 2018 Elsevier GmbH. All rights reserved.
- Published
- 2018
15. Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects
- Author
-
Johnson, B., Lowe, G.C., Futterer, J., Lordkipanidze', M., MacDonald, D., Simpson, M.A., Sanchez Guiu', I., Drake, S., Bem, D., Leo, V., Fletcher, S.J., Dawood, B., Rivera, J., Allsup, D., Biss, T., Bolton-Maggs, P.H.B., Collins, P., Curry, N., Grimley, C., James, B., Makris, M., Motwani, J., Pavord, S., Talks, K., Thachil, J., Wilde, J., Williams, M., Harrison, P., Gissen, P., Mundell, S., Mumford, A., Daly, M.E., Watson, S.P., and Morgan, N.V.
- Subjects
Blood Platelets ,Platelet Count ,Mutation, Missense ,Genetic Variation ,High-Throughput Nucleotide Sequencing ,Humans ,Exome ,Genetic Predisposition to Disease ,Articles ,Thrombocytopenia - Abstract
Inherited thrombocytopenias are a heterogeneous group of disorders characterised\ud by abnormally low platelet counts which can be associated with abnormal bleeding.\ud Next generation sequencing has previously been employed in these disorders for the\ud confirmation of suspected genetic abnormalities, and more recently in the discovery\ud of novel disease causing genes. However its full potential has not previously been\ud utilised. Over the past 6 years we have sequenced the exomes from 55 patients,\ud including 37 index cases and 18 additional family members, all of whom were\ud recruited to the UK Genotyping and Phenotyping of Platelets study. All patients had\ud inherited or sustained thrombocytopenia of unknown aetiology with platelet counts\ud varying from 11-186x109\ud /L. Of the 51 patients phenotypically tested, 37 (73%), had\ud an additional secondary qualitative platelet defect. Using whole exome sequencing\ud analysis we have identified “pathogenic” or “likely pathogenic” variants in 46%\ud (17/37) of our index patients with thrombocytopenia. In addition, we report variants\ud of uncertain significance in 12 index cases which include novel candidate genetic\ud variants in previously unreported genes in four index cases. These results\ud demonstrate that whole exome sequencing is an efficient method for elucidating\ud potential pathogenic genetic variants in inherited thrombocytopenia. Whole exome\ud sequencing also has the added benefit of discovering potentially pathogenic genetic\ud variants for further study in novel genes not previously implicated in inherited\ud thrombocytopenia.
- Published
- 2016
- Full Text
- View/download PDF
16. A mode-based implementation framework for advanced control methods in building automation systems with Petri-Nets
- Author
-
Schild, T., primary, Futterer, J., additional, and Muller, D., additional
- Published
- 2017
- Full Text
- View/download PDF
17. SP-0014: In situ Cancer Vaccines: Tumor destruction and immune stimulation for local and systemic tumor control
- Author
-
Adema, G., primary, Den Brok, M., additional, Van den Bijgaart, R., additional, Wassink, M., additional, Hoogenboom, M., additional, Bussink, J., additional, and Futterer, J., additional
- Published
- 2017
- Full Text
- View/download PDF
18. MR-guided focal laser ablation of prostate cancer: 1-year follow-up
- Author
-
Futterer, J, primary and Sperling, D, additional
- Published
- 2017
- Full Text
- View/download PDF
19. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project
- Author
-
Scheltema, M. J., primary, Tay, K. J., additional, Postema, A. W., additional, de Bruin, D. M., additional, Feller, J., additional, Futterer, J. J., additional, George, A. K., additional, Gupta, R. T., additional, Kahmann, F., additional, Kastner, C., additional, Laguna, M. P., additional, Natarajan, S., additional, Rais-Bahrami, S., additional, Rastinehad, A. R., additional, de Reijke, T. M., additional, Salomon, G., additional, Stone, N., additional, van Velthoven, R., additional, Villani, R., additional, Villers, A., additional, Walz, J., additional, Polascik, T. J., additional, and de la Rosette, J. J. M. C. H., additional
- Published
- 2016
- Full Text
- View/download PDF
20. System of Systems theory as a new perspective on building control
- Author
-
Schild, T., primary, Futterer, J., additional, Sangi, R., additional, Streblow, R., additional, and Muller, D., additional
- Published
- 2015
- Full Text
- View/download PDF
21. SP-0225: Defining the focal volume; how reliable is MR imaging?
- Author
-
Futterer, J., primary
- Published
- 2015
- Full Text
- View/download PDF
22. Abstract No. 186 - MR-guided focal laser ablation of prostate cancer: 1-year follow-up
- Author
-
Futterer, J and Sperling, D
- Published
- 2017
- Full Text
- View/download PDF
23. 582 MR-guided focal cryoablation of prostate cancer recurrence following radiotherapy: A feasibility study
- Author
-
Futterer, J., primary, Bomers, J., additional, Yakar, D., additional, Van Lin, N.J.T., additional, Vergunst, H., additional, De Lange, F., additional, Barentsz, J.O., additional, and Sedelaar, J.P., additional
- Published
- 2013
- Full Text
- View/download PDF
24. 138 Standards in reporting of MRI-targeted prostate biopsies (START): Recommendations from an international working party
- Author
-
Kasivisvanathan, V., primary, Moore, C.M., additional, Eggener, S., additional, Emberton, M., additional, Futterer, J., additional, Gill, I., additional, Grubb, R., additional, Hadaschik, B., additional, Klotz, L., additional, Margolis, D., additional, Marks, L., additional, Melamed, J., additional, Oto, A., additional, Palmer, S., additional, Pinto, P., additional, Pueche, P., additional, Punwani, S., additional, Rosenkrantz, A., additional, Shoots, I., additional, Simon, R., additional, Taneja, S., additional, Turkbey, B., additional, Ukimura, O., additional, Van Der Meulen, J., additional, Villers, A., additional, and Watanabe, Y., additional
- Published
- 2013
- Full Text
- View/download PDF
25. OC10.01: Diagnosing levator defects on 3D transperineal ultrasound compared to MR imaging
- Author
-
Notten, K., primary, Weemhoff, M., additional, Schweitzer, K., additional, Futterer, J., additional, Stoker, J., additional, Mulder, F., additional, Beets‐Tan, R., additional, Vliegen, R., additional, Roovers, J., additional, and Kluivers, K., additional
- Published
- 2012
- Full Text
- View/download PDF
26. EP-1130 MR GUIDED CRYOABLATION OF RECURRENT PROSTATE CANCER AFTER RADIOTHERAPY; A FEASIBILITY STUDY
- Author
-
Futterer, J., primary, Bomers, J.G.R., additional, Sedelaar, M., additional, van Lin, E., additional, Lange, F. de, additional, and Yakar, D., additional
- Published
- 2012
- Full Text
- View/download PDF
27. MP-16.09 Correlation of PCA3 and MRI With Biopsy Outcome
- Author
-
Leyten, G., primary, Wierenga, L., additional, Sedelaar, M., additional, van Oort, I., additional, Futterer, J., additional, Barentsz, J., additional, Schalken, J., additional, and Mulders, P., additional
- Published
- 2011
- Full Text
- View/download PDF
28. 141 INVITED The use of iron particles in MRI
- Author
-
Futterer, J., primary and Barentsz, J.O., additional
- Published
- 2007
- Full Text
- View/download PDF
29. Cone beam CT guidance provides superior accuracy for complex needle paths compared with CT guidance.
- Author
-
BUSSER, W. M. H., BRAAK, S. J., FUTTERER, J. J., VAN STRIJEN, M. J. L., HOOGEVEEN, Y. L., DE LANGE, F., and SCHULTZE KOOL, L. J.
- Subjects
CONE beam computed tomography ,IMAGING phantoms ,FLUOROSCOPY ,INTERVENTIONAL radiology ,ONCOLOGIC surgery - Abstract
Objective: To determine the accuracy of cone beam CT (CBCT) guidance and CT guidance in reaching small targets in relation to needle path complexity in a phantom. Methods: CBCT guidance combines three-dimensional CBCT imaging with fluoroscopy overlay and needle planning software to provide real-time needle guidance. The accuracy of needle positioning, quantified as deviation from a target, was assessed for inplane, angulated and double angulated needle paths. Four interventional radiologists reached four targets along the three paths using CBCT and CT guidance. Accuracies were compared between CBCT and CT for each needle path and between the three approaches within both modalities. The effect of user experience in CBCT guidance was also assessed. Results: Accuracies for CBCT were significantly better than CT for the double angulated needle path (2.2 vs 6.7 mm, p<.001) for all radiologists. CBCT guidance showed no significant differences between the three approaches. For CT, deviations increased with increasing needle path complexity from 3.3mm for the inplane placements to 4.4 mm (p=0.007) and 6.7 mm (p<0.001) for the angulated and double angulated CT-guided needle placements, respectively. For double angulated needle paths, experienced CBCT users showed consistently higher accuracies than trained users [1.8 mm (range 1.2-2.2) vs 3.3mm (range 2.1-7.2) deviation from target, respectively; p=0.003). Conclusion: In terms of accuracy, CBCT is the preferred modality, irrespective of the level of user experience, for more difficult guidance procedures requiring double angulated needle paths as in oncological interventions. Advances in knowledge: Accuracy of CBCT guidance has not been discussed before. CBCT guidance allows accurate needle placement irrespective of needle path complexity. For angulated and double-angulated needle paths, CBCT is more accurate than CT guidance. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
30. Efficient initiation of translation at non‐AUG triplets in plant cells.
- Author
-
Gordon, K, primary, Futterer, J, additional, and Hohn, T, additional
- Published
- 1992
- Full Text
- View/download PDF
31. Cauliflower mosaic virus as a gene expression vector for plants
- Author
-
Futterer, J., primary, Bonneville, J. M., additional, and Hohn, T., additional
- Published
- 1990
- Full Text
- View/download PDF
32. Career Development and Planning - (Applied Areas)
- Author
-
GENERAL HOSPITAL (5TH) APO NEW YORK 09154, Futterer,J. W., GENERAL HOSPITAL (5TH) APO NEW YORK 09154, and Futterer,J. W.
- Abstract
The task group limited itself to professional rather than maintenance issue and operated under certain assumptions: Army psychologists are and will be oriented toward a career in the military. Psychologists in the Army have a need to view career avenues within the military which allow for development and advancement both as a psychologist and a military officer. We operate in a highly structured bureaucracy which needs to be able to view psychologists in a structured career manner and psychologists need to be able to see themselves in a structured career pattern within the bureaucracy. This does not negate the need for flexibility to deal with individual needs and change within the structure. (Future Shock). For career development to be an operational concept, there must be continuity in program development both at a local level and on an Army wide level. (Author), This article is from 'Proceedings of the Current Trends in Army Medical Service Psychology Held at Denver, Colorado on 9-13 December 1974,' AD-A143 409, p80-84.
- Published
- 1974
33. Protocol for Translabial 3D-Ultrasonography for diagnosing levator defects (TRUDIL): a multicentre cohort study for estimating the diagnostic accuracy of translabial 3D-ultrasonography of the pelvic floor as compared to MR imaging
- Author
-
Gondrie Ed TCM, Kampschöer Paul HNM, Bergmans Martin GM, Link Gerold, Evers Johannes LH, Vliegen Roy FA, Futterer Jurgen J, Beets-Tan Regina GH, Stoker Jaap, Mulder Femke, Schweitzer Karlijn J, Kluivers Kirsten B, Weemhoff Mirjam, Notten Kim JB, van Gestel Iris, van Dooren Ivo, Dirksen Carmen, Smits Luc JM, Bossuyt Patrick M, and Roovers Jan
- Subjects
Gynecology and obstetrics ,RG1-991 ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Pelvic organ prolapse (POP) is a condition affecting more than half of the women above age 40. The estimated lifetime risk of needing surgical management for POP is 11%. In patients undergoing POP surgery of the anterior vaginal wall, the re-operation rate is 30%. The recurrence risk is especially high in women with a levator ani defect. Such defect is present if there is a partially or completely detachment of the levator ani from the inferior ramus of the symphysis. Detecting levator ani defects is relevant for counseling, and probably also for treatment. Levator ani defects can be imaged with MRI and also with Translabial 3D ultrasonography of the pelvic floor. The primary aim of this study is to assess the diagnostic accuracy of translabial 3D ultrasonography for diagnosing levator defects in women with POP with Magnetic Resonance Imaging as the reference standard. Secondary goals of this study include quantification of the inter-observer agreement about levator ani defects and determining the association between levator defects and recurrent POP after anterior repair. In addition, the cost-effectiveness of adding translabial ultrasonography to the diagnostic work-up in patients with POP will be estimated in a decision analytic model. Methods/Design A multicentre cohort study will be performed in nine Dutch hospitals. 140 consecutive women with a POPQ stage 2 or more anterior vaginal wall prolapse, who are indicated for anterior colporapphy will be included. Patients undergoing additional prolapse procedures will also be included. Prior to surgery, patients will undergo MR imaging and translabial 3D ultrasound examination of the pelvic floor. Patients will be asked to complete validated disease specific quality of life questionnaires before surgery and at six and twelve months after surgery. Pelvic examination will be performed at the same time points. Assuming a sensitivity and specificity of 90% of 3D ultrasound for diagnosing levator defects in a population of 120 women with POP, with a prior probability of levator ani defects of 40%, we will be able to estimate predictive values with good accuracy (i.e. confidence limits of at most 10% below or above the point estimates of positive and negative predictive values). Anticipating 3% unclassifiable diagnostic images because of technical reasons, and a further safety margin of 10% we plan to recruit 140 patients. Trial registration Nederlands trial register NTR2220.
- Published
- 2011
- Full Text
- View/download PDF
34. A0964 - Four-year follow-up of MRI-guided Transurethral Ultrasound Ablation (TULSA) in men with localized prostate cancer.
- Author
-
Klotz, L.H., Chin, J., Futterer, J., Hatiboglu, G., Pavlovich, C., Koch, M., Penson, D., Relle, J., Raman, S., Lotan, Y., Serrallach, M., Heidenreich, A., Oto, A., Sedelaar, J.M., Tirkes, T., Arora, S., Macura, K., Costa, D., Pantuck, A., and Bomers, J.
- Subjects
- *
PROSTATE cancer patients , *ULTRASONIC imaging - Published
- 2023
- Full Text
- View/download PDF
35. Resectability and ablatability criteria for the treatment of liver only colorectal metastases:Multidisciplinary consensus document from the COLLISION trial group
- Author
-
Simeon J. S. Ruiter, Alette H. Ruarus, Warner Prevoo, Hester J. Scheffer, Ted Vink, Floris J. Rietema, Jan Jaap Janssen, Bart Geboers, Evelien A. C. Schouten, Bente van den Bemd, Robbert S. Puijk, Rutger-Jan Swijnenburg, Arjen Diederik, Francesco De Cobelli, G. Matthijs Kater, Gerie Groot, B.M. Zonderhuis, Fons H. Potters, C.J.A. Haasbeek, Gian Piero Serafino, Sanne Nieuwenhuizen, Mark J. Arntz, Florentine E. F. Timmer, Marleen C. A. M. Melenhorst, Maarten W Nijkamp, Anton F. Engelsman, Karin Nielsen, Kathelijn S. Versteeg, Colin Sietses, Hasan H. Eker, Marielle M.E. Coolsen, Koert P. de Jong, Petrousjka van den Tol, Mark C. Burgmans, Joris I. Erdmann, Wouter K. G. Leclercq, Cornelis H. C. Dejong, Christiaan van der Leij, A. Bruynzeel, Peter B. van den Boezem, Eric R. Manusama, Jurgen J. Fütterer, Jan J. J. de Vries, Luca Aldrighetti, Mark A.J. Meier, Johan W.H. Kruimer, Peter van Duijvendijk, Johannes H. W. de Wilt, Sarah Derks, Geert Kazemier, Bram B. van der Meijs, Martijn R. Meijerink, Surgery, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, CCA - Cancer Treatment and Quality of Life, Radiology and nuclear medicine, Radiation Oncology, Medical oncology, Amsterdam Gastroenterology Endocrinology Metabolism, CCA - Cancer Treatment and quality of life, AGEM - Re-generation and cancer of the digestive system, Nieuwenhuizen, S., Puijk, R. S., van den Bemd, B., Aldrighetti, L., Arntz, M., van den Boezem, P. B., Bruynzeel, A. M. E., Burgmans, M. C., de Cobelli, F., Coolsen, M. M. E., Dejong, C. H. C., Derks, S., Diederik, A., van Duijvendijk, P., Eker, H. H., Engelsman, A. F., Erdmann, J. I., Futterer, J. J., Geboers, B., Groot, G., Haasbeek, C. J. A., Janssen, J. -J., de Jong, K. P., Matthijs Kater, G., Kazemier, G., Kruimer, J. W. H., Leclercq, W. K. G., van der Leij, C., Manusama, E. R., Meier, M. A. J., van der Meijs, B. B., Melenhorst, M. C. A. M., Nielsen, K., Nijkamp, M. W., Potters, F. H., Prevoo, W., Rietema, F. J., Ruarus, A. H., Ruiter, S. J. S., Schouten, E. A. C., Serafino, G. P., Sietses, C., Swijnenburg, R. -J., Timmer, F. E. F., Versteeg, K. S., Vink, T., de Vries, J. J. J., de Wilt, J. H. W., Zonderhuis, B. M., Scheffer, H. J., van den Tol, P. M. P., Meijerink, M. R., Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Institute for Organ Transplantation (GIOT), MUMC+: MA Heelkunde (9), RS: NUTRIM - R2 - Liver and digestive health, and MUMC+: DA BV Medisch Specialisten Radiologie (9)
- Subjects
0301 basic medicine ,Cancer Research ,Partial hepatectomy ,Stereotactic body radiotherapy ,Radiofrequency ablation ,Colorectal cancer ,Ablatability criteria ,Resectability criteria ,ablatability criteria ,Systemic therapy ,law.invention ,Microwave ablation ,Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] ,NEOADJUVANT CHEMOTHERAPY ,0302 clinical medicine ,law ,Irreversible electroporation ,Medicine ,Stage (cooking) ,ELDERLY-PATIENTS ,Consensus guideline ,SURGICAL RESECTION ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,CANCER ,colorectal liver metastases ,Oncology ,stereotactic body radiotherapy ,Urological cancers Radboud Institute for Health Sciences [Radboudumc 15] ,030220 oncology & carcinogenesis ,PHASE-II ,radiofrequency ablation ,consensus guideline ,resectability criteria ,medicine.medical_specialty ,HEPATIC RESECTION ,lcsh:RC254-282 ,Article ,03 medical and health sciences ,thermal ablation ,All institutes and research themes of the Radboud University Medical Center ,irreversible electroporation ,business.industry ,General surgery ,Other Research Radboud Institute for Health Sciences [Radboudumc 0] ,Gold standard ,Cancer ,medicine.disease ,Thermal ablation ,partial hepatectomy ,Colorectal liver metastases ,Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10] ,030104 developmental biology ,microwave ablation ,business - Abstract
The guidelines for metastatic colorectal cancer crudely state that the best local treatment should be selected from a &lsquo, toolbox&rsquo, of techniques according to patient- and treatment-related factors. We created an interdisciplinary, consensus-based algorithm with specific resectability and ablatability criteria for the treatment of colorectal liver metastases (CRLM). To pursue consensus, members of the multidisciplinary COLLISION and COLDFIRE trial expert panel employed the RAND appropriateness method (RAM). Statements regarding patient, disease, tumor and treatment characteristics were categorized as appropriate, equipoise or inappropriate. Patients with ECOG&le, 2, ASA&le, 3 and Charlson comorbidity index &le, 8 should be considered fit for curative-intent local therapy. When easily resectable and/or ablatable (stage IVa), (neo)adjuvant systemic therapy is not indicated. When requiring major hepatectomy (stage IVb), neo-adjuvant systemic therapy is appropriate for early metachronous disease and to reduce procedural risk. To downstage patients (stage IVc), downsizing induction systemic therapy and/or future remnant augmentation is advised. Disease can only be deemed permanently unsuitable for local therapy if downstaging failed (stage IVd). Liver resection remains the gold standard. Thermal ablation is reserved for unresectable CRLM, deep-seated resectable CRLM and can be considered when patients are in poor health. Irreversible electroporation and stereotactic body radiotherapy can be considered for unresectable perihilar and perivascular CRLM 0-5cm. This consensus document provides per-patient and per-tumor resectability and ablatability criteria for the treatment of CRLM. These criteria are intended to aid tumor board discussions, improve consistency when designing prospective trials and advance intersociety communications. Areas where consensus is lacking warrant future comparative studies.
- Published
- 2020
- Full Text
- View/download PDF
36. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)
- Author
-
Bogdan Geavlete, Stefano Fanti, Susanne Krege, Alberto Briganti, Harry W. Herr, Shaista Hafeez, Mark Frydenberg, Marek Babjuk, Willem de Blok, Antti Salminen, Maria De Santis, Yann Neuzillet, Arnulf Stenzl, Joost L. Boormans, Hein Van Poppel, Karel Decaestecker, Vibeke Løgager, Jorg R. Oddens, Silke Gillessen, Pedro C. Lara, Berardino De Bari, Baris Turkbey, Andrew K. Williams, Thomas Wiegel, Mihai Dorin Vartolomei, Robert Jones, Riccardo Valdagni, Vincent Khoo, Ashish M. Kamat, Christoph R. Müller, Georgios Gakis, Neeraj Agarwal, Annemarie Leliveld, Franklin A. Vives Rivera, Robert Jan Smeenk, Luís Pacheco-Figueiredo, H. Maxim Bruins, Juan Palou, Jorge Huguet, Konstantinos Dimitropoulos, Jonathan E. Rosenberg, Carl Salembier, Ken Herrmann, Iris Brummelhuis, Morgan Rouprêt, Helle Pappot, Susanne Osanto, Shahrokh F. Shariat, Anita Smits, Susanne Vahr Lauridsen, Manish I. Patel, Theo H. van der Kwast, Paul Sargos, Michel Bolla, Karin Plass, Jurgen J. Fütterer, Hugh Mostafid, Olivier Rouvière, Valérie Fonteyne, Erik Veskimäe, Bradley R. Pieters, Richard P. Meijer, Anne E. Kiltie, Tom J.H. Arends, Arndt Hartmann, Amir Sherif, Antoni Vilaseca, Stéphane Culine, Wim J.G. Oyen, Evanguelos Xylinas, Daniel Castellano, Shomik Sengupta, James N'Dow, Maria J. Ribal, Mesut Remzi, Richard Zigeuner, A. Müller, Richard Cathomas, Joaquim Bellmunt, Nicholas D. James, Paolo Gontero, Pieter De Visschere, Eva Compérat, Alison Birtle, Margitta Retz, Dickon Hayne, Michael Rink, Virginia Hernández, J. Alfred Witjes, Marco Moschini, J. Domínguez-Escrig, Yohann Loriot, Estefania Linares-Espinós, Peter C. Black, Alberto Bossi, Bertrand Tombal, Sylvain Ladoire, Aristotle Bamias, Ananya Choudhury, Simon J. Crabb, Steven MacLennan, Peter Wiklund, Antoine G. van der Heijden, Arturo Chiti, Bernhard Grubmüller, Barbara Alicja Jereczek-Fossa, Alan Horwich, George N. Thalmann, Bernard H. Bochner, Florian Roghmann, Max Bürger, Jan Oldenburg, Peter Hoskin, Andrea Necchi, Jonathan Richenberg, Anja Lorch, Peter Paul M. Willemse, Donna E. Hansel, M. Carmen Mir, Thomas Powles, Theo M. de Reijke, Ann Henry, Witjes, J. A., Babjuk, M., Bellmunt, J., Bruins, H. M., De Reijke, T. M., De Santis, M., Gillessen, S., James, N., Maclennan, S., Palou, J., Powles, T., Ribal, M. J., Shariat, S. F., Van Der Kwast, T., Xylinas, E., Agarwal, N., Arends, T., Bamias, A., Birtle, A., Black, P. C., Bochner, B. H., Bolla, M., Boormans, J. L., Bossi, A., Briganti, A., Brummelhuis, I., Burger, M., Castellano, D., Cathomas, R., Chiti, A., Choudhury, A., Comperat, E., Crabb, S., Culine, S., De Bari, B., De Blok, W., De Visschere, P. J. L., Decaestecker, K., Dimitropoulos, K., Dominguez-Escrig, J. L., Fanti, S., Fonteyne, V., Frydenberg, M., Futterer, J. J., Gakis, G., Geavlete, B., Gontero, P., Grubmuller, B., Hafeez, S., Hansel, D. E., Hartmann, A., Hayne, D., Henry, A. M., Hernandez, V., Herr, H., Herrmann, K., Hoskin, P., Huguet, J., Jereczek-Fossa, B. A., Jones, R., Kamat, A. M., Khoo, V., Kiltie, A. E., Krege, S., Ladoire, S., Lara, P. C., Leliveld, A., Linares-Espinos, E., Logager, V., Lorch, A., Loriot, Y., Meijer, R., Mir, M. C., Moschini, M., Mostafid, H., Muller, A. -C., Muller, C. R., N'Dow, J., Necchi, A., Neuzillet, Y., Oddens, J. R., Oldenburg, J., Osanto, S., Oyen, W. J. G., Pacheco-Figueiredo, L., Pappot, H., Patel, M. I., Pieters, B. R., Plass, K., Remzi, M., Retz, M., Richenberg, J., Rink, M., Roghmann, F., Rosenberg, J. E., Roupret, M., Rouviere, O., Salembier, C., Salminen, A., Sargos, P., Sengupta, S., Sherif, A., Smeenk, R. J., Smits, A., Stenzl, A., Thalmann, G. N., Tombal, B., Turkbey, B., Lauridsen, S. V., Valdagni, R., Van Der Heijden, A. G., Van Poppel, H., Vartolomei, M. D., Veskimae, E., Vilaseca, A., Rivera, F. A. V., Wiegel, T., Wiklund, P., Willemse, P. -P. M., Williams, A., Zigeuner, R., Horwich, A., Urology, APH - Personalized Medicine, APH - Quality of Care, CCA - Cancer Treatment and Quality of Life, Radiotherapy, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, and UCL - (SLuc) Service d'urologie
- Subjects
medicine.medical_specialty ,Bladder cancer ,business.industry ,Urology ,030232 urology & nephrology ,MEDLINE ,Cancer ,Regret ,medicine.disease ,3. Good health ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Medicine ,Urologia ,University medical ,Bufeta -- Càncer ,Protocols clínics ,business - Abstract
The authors regret that a co-author was mistakenly missed from the authorship. The following co-author should have been included in the authorship: Peter-Paul M. Willemse Department of Oncological Urology, University Medical Center, Utrecht Cancer Center, Utrecht, The Netherlands
- Published
- 2020
37. Initial validation of the Health Environment Rating Scale-Early Childhood Consultation-Classroom (HERS-ECC-C).
- Author
-
Futterer J, Mullins C, Bulotsky-Shearer RJ, Guzmán E, Hildago T, Kolomeyer E, Howe E, Horen N, Sanders LM, and Natale R
- Subjects
- Humans, Female, Male, Child, Preschool, Reproducibility of Results, Surveys and Questionnaires, Factor Analysis, Statistical, Child Day Care Centers, Southeastern United States, Social Environment, Psychometrics methods
- Abstract
The present study validated a newly developed easy-to-use observational instrument, the Health Environment Rating Scale-Early Childhood Consultation-Classroom version (HERS-ECC-C), to measure the quality of the classroom environment within early care and education centers participating in a mental health consultation program in a diverse area of the southeastern United States. Using a confirmatory factor analysis, three factors emerged capturing critical aspects of a high-quality classroom environment and demonstrated good reliability: (1) Supportive Practices, Positive Socioemotional Practices, and Classroom Management (α = .88), (2) Health and Family Communication (α = .79), and (3) Individualizing to Children's Needs (α = .80). Criterion-related validity was established through concurrent associations between the three HERS-ECC-C subscales and the domains of the Classroom Assessment Scoring System (CLASS) and predictive associations with the Childcare Worker Job Stress Inventory. The HERS-ECC-C Supportive Practices and Health and Family Communication subscales were associated with all three CLASS domains, and the Individualizing to Children's Needs subscale was associated with the CLASS Instructional support domain. Higher HERS-ECC-C subscale scores were associated with lower teacher-reported job stress. Findings provide initial evidence to support the use and continued development of the HERS-ECC-C as a tool to evaluate programs and classrooms engaged in mental health consultation professional development interventions., (© 2024 The Author(s). Infant Mental Health Journal published by Wiley Periodicals LLC on behalf of Michigan Association for Infant Mental Health.)
- Published
- 2024
- Full Text
- View/download PDF
38. Infant and early childhood mental health consultation in a diverse metropolitan area.
- Author
-
Natale R, Kolomeyer E, Futterer J, Mahmoud FD, Schenker M, Robleto A, Horen N, and Spector R
- Subjects
- Child, Preschool, Cultural Diversity, Humans, Infant, Mental Health, Referral and Consultation
- Abstract
IECMHC can and should be a vehicle that promotes greater equity in access to high quality relationships within an early classroom environment. It is important to consider consultation through a racial equity lens to ensure that it is integrated in all levels of work. The goal of the study was to replicate the results from other IECMHC programs with a diverse, largely Latinx, population. The Jump Start program was given the unique opportunity to adapt the Georgetown Framework of Infant and Early Childhood Mental Health Consultation to a multicultural population in Miami. A total of 88 early learning programs and 244 teachers participated. Services were provided in English, Spanish, and Creole at the program- and classroom-level. Pre- and post-data were collected at both levels. Significant improvements at the program- and classroom-level were found post-consultation. Consultants demonstrated fidelity to core program practices while providing culturally and linguistically competent service. The current study replicated findings regarding the effectiveness of IECMHC while expanding results to a diverse metropolitan community. Key features of program success may be attributed to the use of highly trained consultants, action planning, fidelity monitoring, and enrollment of programs that were ready and have a champion for IECMHC., (© 2022 Michigan Association for Infant Mental Health.)
- Published
- 2022
- Full Text
- View/download PDF
39. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.
- Author
-
Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, Schoots IG, Moore CM, Futterer J, Macura KJ, Oto A, Bittencourt LK, Haider MA, Salomon G, Tempany CM, Padhani AR, and Barentsz JO
- Subjects
- Consensus, Humans, Magnetic Resonance Imaging, Male, Neoplasm Recurrence, Local diagnostic imaging, Prostate, Prostate-Specific Antigen, Prostatectomy, Multiparametric Magnetic Resonance Imaging, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms radiotherapy, Prostatic Neoplasms surgery
- Abstract
Background: Imaging techniques are used to identify local recurrence of prostate cancer (PCa) for salvage therapy and to exclude metastases that should be addressed with systemic therapy. For magnetic resonance imaging (MRI), a reduction in the variability of acquisition, interpretation, and reporting is required to detect local PCa recurrence in men with biochemical relapse after local treatment with curative intent., Objective: To propose a standardised method for image acquisition and assessment of PCa local recurrence using MRI after radiation therapy (RP) and radical prostatectomy (RT)., Evidence Acquisition: Prostate Imaging for Recurrence Reporting (PI-RR) was formulated using the existing literature. An international panel of experts conducted a nonsystematic review of the literature. The PI-RR system was created via consensus through a combination of face-to-face and online discussions., Evidence Synthesis: Similar to with PI-RADS, based on the best available evidence and expert opinion, the minimum acceptable MRI parameters for detection of recurrence after radiation therapy and radical prostatectomy are set. Also, a simplified and standardised terminology and content of the reports that use five assessment categories to summarise the suspicion of local recurrence (PI-RR) are designed. PI-RR scores of 1 and 2 are assigned to lesions with a very low and low likelihood of recurrence, respectively. PI-RR 3 is assigned if the presence of recurrence is uncertain. PI-RR 4 and 5 are assigned for a high and very high likelihood of recurrence, respectively. PI-RR is intended to be used in routine clinical practice and to facilitate data collection and outcome monitoring for research., Conclusions: This paper provides a structured reporting system (PI-RR) for MRI evaluation of local recurrence of PCa after RT and RP., Patient Summary: A new method called PI-RR was developed to promote standardisation and reduce variations in the acquisition, interpretation, and reporting of magnetic resonance imaging for evaluating local recurrence of prostate cancer and guiding therapy., (Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
40. The utility of in-bore multiparametric magnetic resonance-guided biopsy in men with negative multiparametric magnetic resonance-ultrasound software-based fusion targeted biopsy.
- Author
-
Perrin A, Venderink W, Patak MA, Möckel C, Fehr JL, Jichlinski P, Porcellini B, Lucca I, Futterer J, and Valerio M
- Subjects
- Aged, Humans, Image-Guided Biopsy methods, Male, Middle Aged, Retrospective Studies, Software, Ultrasonography, Multiparametric Magnetic Resonance Imaging, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology
- Abstract
Objectives: To evaluate the utility of in-bore multiparametric magnetic resonance-guided biopsy of the prostate (IB) in patients with visible lesion/s and previous negative software-based multiparametric magnetic resonance imaging/ultrasonography fusion-targeted biopsy of the prostate (FTB)., Patients and Methods: We retrospectively analysed prospectively maintained database including consecutive men undergoing IB from March 2013 to October 2017 in 2 European centres expert in this procedure. We selected men with the following criteria: No previous treatment for prostate cancer (CaP), multiparametric magnetic resonance imaging (mpMRI) lesion(s) PIRADS score ≥ 3, FTB showing no clinically significant cancer (csCaP), and subsequent IB. Patient's characteristics, mpMRI findings, biopsy technique, and histopathological results were extracted. The primary outcome was to determine the detection rate of csCaP, defined as any Gleason pattern ≥ 4. A multivariable analysis was performed to identify predictors of positive findings at IB., Results: Fifty-three men were included. Median age was 68 years (interquartile range [IQR] 64-68), median Prostate-Specific Antigen (PSA) was 7.6 ng/ml (IQR 5.2-10.9), and median prostate volume was 59 ml (IQR 44-84). Fifty-six lesions with PIRADS score 3 in 9 cases (16%), 4 in 30 cases (54%), and 5 in 17 cases (30%) were detected. FTB was performed in all cases using a transrectal approach with 3 different platforms (Toshiba, Koelis, and Artemis). Median time between FTB and IB was 3 months (IQR 1-7). A median of 2 cores per lesion were collected with IB (IQR 2-3). No cancer, clinically insignificant and clinically significant cancer were found in 33 (59%), 9 (16%), and 14 (25%) targeted lesions, respectively. Median maximum cancer core length and maximum positive percentage were 9 mm (3-13) and 55% (21%-80%). The only predictor of csCaP on IB was prostate volume (P = 0.026) with an ideal cut-off at 70 ml., Conclusion: One in 4 patients with previous negative FTB, IB was able to detect csCaP. According to this study, IB would be of particularly useful in patients with large glands., Competing Interests: Declaration of competing interest No conflict of interest was declared by the authors., (Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
41. Percutaneous Nephrolithotomy with Intraoperative Computed Tomography Scanning Improves Stone-Free Rates.
- Author
-
Van den Broeck T, Zhu X, Kusters A, Futterer J, Langenhuijsen J, and d'Ancona F
- Subjects
- Humans, Prospective Studies, Retrospective Studies, Treatment Outcome, Kidney Calculi diagnostic imaging, Kidney Calculi surgery, Nephrolithotomy, Percutaneous adverse effects, Nephrostomy, Percutaneous
- Abstract
Introduction: The use of fluoroscopy during percutaneous nephrolithotomy (PCNL) may lead to an overestimation of stone-free rates. The objective of this study is to demonstrate the feasibility of intraoperative CT-guided PCNL compared with standard of care (SoC) PCNL. Patients and Methods: A prospective feasibility study (20 patients undergoing PCNL with an intraoperative CT scan between June 2017 and February 2020) and a retrospective study of a historical cohort (20 consecutive patients undergoing SoC PCNL between September 2015 and September 2016) were conducted. All procedures were performed by an expert endourologist in a tertiary referral hospital. Follow-up was performed at 6 weeks postoperatively. The primary goal is to investigate the practicality and potential benefits and harms of intraoperative CT scanning during PCNL. Secondary outcomes are a stone-free rate after the 6-week follow-up, perioperative radiation exposure, the need for postoperative imaging, and peri- and postoperative complications. Statistical significance was considered at p < 0.05. Results: The initial stone-free rate in the CT scan group was 65% ( n = 13). In 25% ( n = 5) of patients, residual stone fragments were removed after the perioperative CT scan. In the SoC group, 85% ( n = 17) of patients were thought to be stone free perioperatively. At the 6-week follow-up, 80% ( n = 16) in the CT scan group vs 50% in the SoC group ( n = 10) were found to be stone free. Radiation exposure, perioperatively, was higher in the CT scan group. Complications were comparable between groups. Limitations of the study are the nonrandomized design of the study and nonstandardized follow-up imaging. Conclusions: Intraoperative CT scanning during PCNL is feasible and gives a better estimate of any remaining stone fragments compared with fluoroscopy only.
- Published
- 2021
- Full Text
- View/download PDF
42. Need for Systematic Magnetic Resonance Imaging Interpretation and Reporting after Partial Prostate Gland Ablation.
- Author
-
Hu JC, Basourakos SP, and Futterer J
- Subjects
- Ablation Techniques, Humans, Image Interpretation, Computer-Assisted, Male, Research Design, Magnetic Resonance Imaging, Prostatectomy methods, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms surgery
- Abstract
Interpretation guidelines for prostate multiparametric magnetic resonance imaging findings in the post-ablation setting are not available yet; this poses a significant challenge for accurate risk stratification in this clinical setting. Here we propose the development and implementation of a post-ablation Prostate Imaging-Reporting and Data System that would improve patient surveillance and management after prostate ablation for localized prostate cancer., (Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
43. Definitions of Computer-Assisted Surgery and Intervention, Image-Guided Surgery and Intervention, Hybrid Operating Room, and Guidance Systems: Strasbourg International Consensus Study.
- Author
-
Giménez M, Gallix B, Costamagna G, Vauthey JN, Moche M, Wakabayashi G, Bale R, Swanström L, Futterer J, Geller D, Verde JM, García Vazquez A, Boškoski I, Golse N, Müller-Stich B, Dallemagne B, Falkenberg M, Jonas S, Riediger C, Diana M, Kvarnström N, Odisio BC, Serra E, Overduin C, Palermo M, Mutter D, Perretta S, Pessaux P, Soler L, Hostettler A, Collins T, Cotin S, Kostrzewa M, Alzaga A, Smith M, and Marescaux J
- Abstract
Objective: To develop consensus definitions of image-guided surgery, computer-assisted surgery, hybrid operating room, and surgical navigation systems., Summary Background Data: The use of minimally invasive procedures has increased tremendously over the past 2 decades, but terminology related to image-guided minimally invasive procedures has not been standardized, which is a barrier to clear communication., Methods: Experts in image-guided techniques and specialized engineers were invited to engage in a systematic process to develop consensus definitions of the key terms listed above. The process was designed following review of common consensus-development methodologies and included participation in 4 online surveys and a post-surveys face-to-face panel meeting held in Strasbourg, France., Results: The experts settled on the terms computer-assisted surgery and intervention, image-guided surgery and intervention, hybrid operating room, and guidance systems and agreed-upon definitions of these terms, with rates of consensus of more than 80% for each term. The methodology used proved to be a compelling strategy to overcome the current difficulties related to data growth rates and technological convergence in this field., Conclusions: Our multidisciplinary collaborative approach resulted in consensus definitions that may improve communication, knowledge transfer, collaboration, and research in the rapidly changing field of image-guided minimally invasive techniques., Competing Interests: Disclosure: M.G.: advisor Siemens, Medtronic; B.G.: CEO of IHU; G.C.: Advisory board Olympus, Cook Medical, Grant Research Boston Scientific; L.S.: employee of IHU, being Siemens one of its partners; I.B.: Apollo Endosurgery Research Grant holder and consultant for Boston Scientific, Apollo Endosurgery and Cook Medical; C.R.: Cooperation and invited talks sponsored by Siemens; B.O.: Research Grant: Siemens Healthineers and NIH R01CA235564; R.B.: advisor Cascination, non-financial support from iSys Medizintechnik during the conduct of the study; L.S.o.: is president of Visible Patient; A.H.: IRCAD employee; A.A.: Siemens Healthineers Advanced Therapies employee; J.M.: President of IRCAD and IHU, which are partly funded by Karl Storz, Medtronic, and Siemens Healthcare. During the face-to-face panel meeting, Siemens provided unrestricted academic sponsoring and funded it partially., (Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
44. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
- Author
-
Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Van Der Kwast T, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, DeBlok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Carmen Mir M, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Vahr Lauridsen S, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Vives Rivera FA, Wiegel T, Wiklund P, Williams A, Zigeuner R, and Witjes JA
- Subjects
- Delphi Technique, Europe, Humans, International Cooperation, Medical Oncology methods, Neoplasm Staging, Societies, Medical standards, Stakeholder Participation, Surveys and Questionnaires, Urinary Bladder pathology, Urinary Bladder Neoplasms pathology, Urology methods, Consensus, Medical Oncology standards, Practice Guidelines as Topic, Urinary Bladder Neoplasms therapy, Urology standards
- Abstract
Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial., Objective: To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management., Design: A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a Delphi survey. Statements not reaching consensus were reviewed; those prioritised were revised by a panel of 45 experts before voting during a consensus conference., Setting: Online Delphi survey and consensus conference., Participants: The European Association of Urology (EAU), the European Society for Medical Oncology (ESMO), experts in bladder cancer management., Outcome Measurements and Statistical Analysis: Statements were ranked by experts according to their level of agreement: 1-3 (disagree), 4-6 (equivocal), 7-9 (agree). A priori (level 1) consensus was defined as ≥70% agreement and ≤15% disagreement, or vice versa. In the Delphi survey, a second analysis was restricted to stakeholder group(s) considered to have adequate expertise relating to each statement (to achieve level 2 consensus)., Results and Limitations: Overall, 116 statements were included in the Delphi survey. Of these, 33 (28%) statements achieved level 1 consensus and 49 (42%) statements achieved level 1 or 2 consensus. At the consensus conference, 22 of 27 (81%) statements achieved consensus. These consensus statements provide further guidance across a broad range of topics, including the management of variant histologies, the role/limitations of prognostic biomarkers in clinical decision making, bladder preservation strategies, modern radiotherapy techniques, the management of oligometastatic disease and the evolving role of checkpoint inhibitor therapy in metastatic disease., Conclusions: These consensus statements provide further guidance on controversial topics in advanced and variant bladder cancer management until a time where further evidence is available to guide our approach., (© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
45. Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches.
- Author
-
Warlick C, Futterer J, Maruf M, George AK, Rastinehad AR, Pinto PA, Bosaily AE, Villers A, Moore CM, Mendhiratta N, Taneja SS, Ukimura O, and Konety BR
- Subjects
- Biopsy, Endosonography, Humans, Magnetic Resonance Imaging, Male, Prostate diagnostic imaging, Prostatic Neoplasms diagnostic imaging, Biopsy, Large-Core Needle methods, Image-Guided Biopsy methods, Prostate pathology, Prostatic Neoplasms pathology
- Abstract
Objectives: Recent advances have led to the use of magnetic resonance imaging (MRI) alone or with fusion to transrectal ultrasound (TRUS) images for guiding biopsy of the prostate. Our group sought to develop consensus recommendations regarding MRI-guided prostate biopsy based on currently available literature and expert opinion., Methods: The published literature on the subject of MRI-guided prostate biopsy was reviewed using standard search terms and synthesized and analyzed by four different subgroups from among the authors. The literature was grouped into four categories-MRI-guided biopsy platforms, robotic MRI-TRUS fusion biopsy, template mapping biopsy and transrectal MRI-TRUS fusion biopsy. Consensus recommendations were developed using the Oxford Center for Evidence Based Medicine criteria., Results: There is limited high level evidence available on the subject of MRI-guided prostate biopsy. MRI guidance with or without TRUS fusion can lead to fewer unnecessary biopsies, help identify high-risk (Gleason ≥ 3 + 4) cancers that might have been missed on standard TRUS biopsy and identify cancers in the anterior prostate. There is no apparent significant difference between MRI biopsy platforms. Template mapping biopsy is perhaps the most accurate method of assessing volume and grade of tumor but is accompanied by higher incidence of side effects compared to TRUS biopsy., Conclusions: Magnetic resonance imaging-guided biopsies are feasible and better than traditional ultrasound-guided biopsies for detecting high-risk prostate cancer and anterior lesions. Judicious use of MRI-guided biopsy could enhance diagnosis of clinically significant prostate cancer while limiting diagnosis of insignificant cancer.
- Published
- 2019
- Full Text
- View/download PDF
46. MR imaging-guided prostate interventional imaging: Ready for a clinical use?
- Author
-
Cornud F, Bomers J, Futterer JJ, Ghai S, Reijnen JS, and Tempany C
- Subjects
- Equipment Design, Humans, Image-Guided Biopsy instrumentation, Image-Guided Biopsy methods, Male, Prostatic Neoplasms surgery, Magnetic Resonance Imaging, Interventional instrumentation, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms pathology
- Abstract
Prostate interventional magnetic resonance imaging (MRI) is now routinely performed in many centers. Its more widespread acceptance is limited by the cost of the use of MRI largely related to the long duration time of the procedures. However, the benefit of a robotic assistance has generated a new interest, because it substantially shortens the procedure time, while improving the accuracy. MRI-guided biopsy is considered as an appealing alternative to transrectal ultrasound (TRUS)-guided fusion biopsy, given the limitations of TRUS-MRI image registration systems. MRI-guided focal treatment also benefits from robotic assistance and from the unique property of MRI, which allows the measurement of the temperature in real-time during tumor ablation. The transrectal and transperineal approaches can be used and the respective indications of each pathway will depend on several factors, including the location of the tumor and the examination time, which will condition the occupation time of the MR room, a major factor influencing the overall cost of MRI-guided procedures. This review addresses the current practice of prostate MRI-guided interventional procedures and potential future applications., (Copyright © 2018 Soci showét showé françaises de radiologie. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
47. Mutation in GNE is associated with severe congenital thrombocytopenia.
- Author
-
Futterer J, Dalby A, Lowe GC, Johnson B, Simpson MA, Motwani J, Williams M, Watson SP, and Morgan NV
- Subjects
- Child, Child, Preschool, Female, Humans, Male, Mutation, Pedigree, Multienzyme Complexes genetics, Thrombocytopenia congenital, Thrombocytopenia genetics
- Published
- 2018
- Full Text
- View/download PDF
48. Medical students' perspective on training in anatomy.
- Author
-
Triepels CPR, Koppes DM, Van Kuijk SMJ, Popeijus HE, Lamers WH, van Gorp T, Futterer JJ, Kruitwagen RFPM, and Notten KJB
- Subjects
- Adolescent, Adult, Attitude of Health Personnel, Audiovisual Aids, Cross-Sectional Studies, Curriculum, Education, Medical, Undergraduate, Educational Measurement, Female, Focus Groups, Humans, Learning, Male, Young Adult, Anatomy education, Students, Medical
- Abstract
Gaining sufficient knowledge of anatomy is an important part of medical education. Factors that influence how well students learn anatomical structures include available sources, learning time and study assistance. This study explores the attitude of medical students with regard to studying anatomy and evaluates possibilities for improvement of training in anatomy. Twenty medical students participated in a focus group meeting. Based on this focus group, an online survey consisting of 27 questions was developed and distributed amongst medical students of Maastricht University, the Netherlands. A total of 495 medical students (both Bachelor and Master level) participated in this survey. Master students found studying anatomy less attractive than Bachelor students (36.8% of the Master students vs. 47.9% of the Bachelor students (p=.024)). Although most students responded that they thought it is important to study anatomy, 48% of all students studied anatomy less than 10h per study block of 8 weeks. Only 47.9% of the students rated their knowledge of anatomy as adequate. Students suggested that three-dimensional techniques would help improve their knowledge of anatomy. Therefore investing in three-dimensional tools could prove beneficial in the future., (Copyright © 2018 Elsevier GmbH. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
49. GPU-based RFA simulation for minimally invasive cancer treatment of liver tumours.
- Author
-
Mariappan P, Weir P, Flanagan R, Voglreiter P, Alhonnoro T, Pollari M, Moche M, Busse H, Futterer J, Portugaller HR, Sequeiros RB, and Kolesnik M
- Subjects
- Carcinoma, Hepatocellular diagnostic imaging, Computer Simulation, Humans, Liver Neoplasms diagnostic imaging, Minimally Invasive Surgical Procedures, Models, Theoretical, Perfusion Imaging, Retrospective Studies, Surgery, Computer-Assisted, Tomography, X-Ray Computed, Carcinoma, Hepatocellular surgery, Catheter Ablation methods, Computer Graphics, Liver Neoplasms surgery
- Abstract
Purpose: Radiofrequency ablation (RFA) is one of the most popular and well-standardized minimally invasive cancer treatments (MICT) for liver tumours, employed where surgical resection has been contraindicated. Less-experienced interventional radiologists (IRs) require an appropriate planning tool for the treatment to help avoid incomplete treatment and so reduce the tumour recurrence risk. Although a few tools are available to predict the ablation lesion geometry, the process is computationally expensive. Also, in our implementation, a few patient-specific parameters are used to improve the accuracy of the lesion prediction., Methods: Advanced heterogeneous computing using personal computers, incorporating the graphics processing unit (GPU) and the central processing unit (CPU), is proposed to predict the ablation lesion geometry. The most recent GPU technology is used to accelerate the finite element approximation of Penne's bioheat equation and a three state cell model. Patient-specific input parameters are used in the bioheat model to improve accuracy of the predicted lesion., Results: A fast GPU-based RFA solver is developed to predict the lesion by doing most of the computational tasks in the GPU, while reserving the CPU for concurrent tasks such as lesion extraction based on the heat deposition at each finite element node. The solver takes less than 3 min for a treatment duration of 26 min. When the model receives patient-specific input parameters, the deviation between real and predicted lesion is below 3 mm., Conclusion: A multi-centre retrospective study indicates that the fast RFA solver is capable of providing the IR with the predicted lesion in the short time period before the intervention begins when the patient has been clinically prepared for the treatment.
- Published
- 2017
- Full Text
- View/download PDF
50. Identifying Quantitative In Vivo Multi-Parametric MRI Features For Treatment Related Changes after Laser Interstitial Thermal Therapy of Prostate Cancer.
- Author
-
Viswanath S, Toth R, Rusu M, Sperling D, Lepor H, Futterer J, and Madabhushi A
- Abstract
Laser interstitial thermal therapy (LITT) is a new therapeutic strategy being explored in prostate cancer (CaP), which involves focal ablation of organlocalized tumor via an interstitial laser fiber. While little is known about treatment-related changes following LITT, studying post-LITT changes via imaging is extremely significant for enabling early image-guided intervention and follow-up. In this work, we present the first attempt at examining focal treatment-related changes on a per-voxel basis via quantitative comparison of MRI features pre- and post-LITT, and hence identifying computerized MRI features that are highly sensitive as well as specific to post-LITT changes within the ablation zone in the prostate. A retrospective cohort of 5 patient datasets comprising both pre- and post-LITT T2-weighted (T2w) and diffusion-weighted (DWI) acquisitions was considered, where DWI MRI yielded an Apparent Diffusion Co-efficient (ADC) map. Our scheme involved (1) inter-protocol registration of T2w and ADC MRI, as well as inter-acquisition registration of pre- and post-LITT MRI, (2) quantitation of MRI parameters by correcting for intensity drift in order to examine tissuespecific response, and (3) quantification of the information captured by T2w MRI and ADC maps via texture and intensity features. Correction of parameter drift resulted in visually discernible improvements in highlighting tissue-specific response in different MRI features. Quantitative, voxel-wise comparison of the changes in different MRI features indicated that steerable and non-steerable gradient texture features, rather than the original T2w intensity and ADC values, were highly sensitive as well as specific in identifying changes within the ablation zone pre- and post-LITT. The highest ranked texture feature yielded a normalized percentage change of 186% within the ablation zone and 43% in a spatially distinct normal region, relative to its pre-LITT value. By comparison, both the original T2w intensity and ADC value demonstrated a markedly less sensitive and specific response to changes within the ablation zone. Qualitative as well as quantitative evaluation of co-occurrence texture features indicated the presence of LITT-related effects such as edema adjacent to the ablation zone, which were indiscernible on the original T2w and ADC images. Our preliminary results thus indicate great potential for non-invasive computerized MRI imaging features for determining focal treatment related changes, informing image-guided interventions, as well as predicting long- and short-term patient outcome.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.